News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genovis Receives SEK 1.575 Million From VINNOVA


3/26/2013 11:01:17 AM

VINNOVA (Swedish Agency for Innovation Systems) chose to support the project “Nanoparticles in movement serve as contrast agents in medical ultrasound,” which Genovis runs together with Associate Professor Tomas Jansson’s research group at the Department of Measurement Technology and Industrial Electrical Engineering, Lund Institute of Technology (LTH). So far the project has resulted in a contrast agent and a method that is unique to ultrasound. This method uses a variable magnetic field that causes magnetic nanoparticles to move in tissue. The movement can be detected by ultrasound.

Read at GlobeNewswire


comments powered by Disqus
Genovis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES